Pharmaceuticals
Reckitt Benckiser to acquire Mead Johnson for $16.6 bn in cash
10 Feb 2017
The deal will help Reckitt Benckiser boost its consumer-health business and push deeper into emerging markets with Mead Johnson's portfolio
Spread of drug-resistant malaria bug should worry India: expert
04 Feb 2017
Detection of malaria parasites resistant to the frontline artemisinin (ART) combination therapy in some south Asian countries should worry India, Govindarajan Padmanabhan, a top biochemist and malaria researcher at the Indian Institute of Science in Bengaluru, has warned
Pfizer explores sale of some treatment drugs worth over $2 bn
03 Feb 2017
As a part of its plan to raise cash and streamline its portfolio, Pfizer will sell its cardiology, urology and primary care treatment drugs
Trump tells drug makers to get prices down
01 Feb 2017
